Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) was the target of a large drop in short interest in May. As of May 15th, there was short interest totaling 1,804,605 shares, a drop of 72.7% from the April 30th total of 6,612,971 shares. Based on an average trading volume of 1,881,607 shares, the short-interest ratio is presently 1.0 days. Approximately 0.3% of the shares of the company are short sold.
Curaleaf Stock Performance
OTCMKTS CURLF traded up $0.03 during trading on Friday, hitting $3.59. The company’s stock had a trading volume of 524,926 shares, compared to its average volume of 1,081,231. The company has a quick ratio of 0.74, a current ratio of 1.56 and a debt-to-equity ratio of 1.05. The firm has a 50 day moving average price of $2.95 and a 200 day moving average price of $2.68. The firm has a market cap of $2.51 billion, a P/E ratio of -27.63 and a beta of 1.58. Curaleaf has a 52 week low of $0.72 and a 52 week high of $5.05.
Curaleaf shares are set to reverse split before the market opens on Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, June 4th.
Analyst Ratings Changes
Separately, Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.
Get Our Latest Stock Report on Curaleaf
About Curaleaf
Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.
Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.
Featured Stories
- Five stocks we like better than Curaleaf
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
